Quantum Pharma PLC Grant of SAYE options (5135K)
July 10 2017 - 2:00AM
UK Regulatory
TIDMQP.
RNS Number : 5135K
Quantum Pharma PLC
10 July 2017
For immediate release 10 July 2017
Quantum Pharma Plc
('Quantum' or the 'Company')
Grant of SAYE options
Quantum Pharma Plc (AIM: QP.), the service-led niche
pharmaceutical developer, manufacturer and supplier is pleased to
announce that on 7 July 2017 pursuant to the Quantum Pharma Plc
Save-As-You-Earn Plan (SAYE), the Company has granted options,
under which employees have been offered the opportunity to
participate in the future growth of the Company via share option
arrangements.
UK and Greek based employees were invited to subscribe for
options over the Company's Ordinary Shares of 10 pence each
('Ordinary Shares') with an exercise price of 42.87 pence, a 20%
discount to the average closing middle market price of the
Company's Ordinary Shares on 9, 12 and 13 June 2017, the three
trading days prior to the invitation to participate was made. The
options have a contract start date of 1 September 2017 and are
exercisable between 1 September 2020 and 28 February 2021.
A total of 98 employees elected to participate, and pursuant to
these elections a total of 981,519 options over Ordinary Shares
have been issued, equating to approximately 0.58% of the current
issued share capital.
Following the above SAYE grant and other recent lapses or grants
of Long Term Incentive Plan options (LTIP) or earlier SAYE grants,
there are outstanding options over 16,243,928 Ordinary Shares,
representing approximately 9.61% of the current issued share
capital, of which options over 15,610,828 Ordinary Shares are
included in the calculation of the 10% limit under the LTIP and
SAYE share plan rules.
- Ends -
For further information:
Quantum Pharma Plc
Chris Rigg, Chief Executive Tel: +44 (0) 1207 279 404
Officer
Gerard Murray, Chief Financial www.quantumpharmaplc.com
Officer
ir@quantumpharma.co.uk
N+1 Singer
(Nominated Advisor & Broker)
Sandy Fraser / Nick Owen / James Tel: +44 (0) 20 7496 3000
White
Media enquiries:
Buchanan
Sophie Cowles / Steph Watson Tel: +44 (0) 20 7466 5000
quantumpharma@buchanan.uk.com www.buchanan.uk.com
Notes to Editors
Quantum Pharma Plc is a service-led, niche pharmaceutical
developer, manufacturer and supplier to the retail pharmacy,
pharmaceutical wholesale and hospital markets. Quantum Pharma Plc
operates through two divisions - Specials and Niche Pharmaceuticals
- offering a portfolio of innovative and complementary products and
services.
For further information, please visit
www.quantumpharmagroup.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEAKXXESEXEFF
(END) Dow Jones Newswires
July 10, 2017 02:00 ET (06:00 GMT)
Quantum Phar. (LSE:QP.)
Historical Stock Chart
From Apr 2024 to May 2024
Quantum Phar. (LSE:QP.)
Historical Stock Chart
From May 2023 to May 2024